Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74607815)
Watch
English
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996
scientific article published on 01 May 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
title
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author name string
L Denis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
language of work or name
English
0 references
publication date
1 May 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
volume
51
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
issue
5A Suppl
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
page(s)
50-57
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
cites work
Treatment response criteria for prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liarozole (R75251) in hormone-resistant prostate cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urolo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900076-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(98)00076-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
PubMed publication ID
9610558
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9610558
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610558%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
